Journal articles on the topic 'Kinase inhibitor treatments'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Kinase inhibitor treatments.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Gäbler, Karoline, Catherine Rolvering, Valérie Palissot, Guy J. Berchem, Iris Behrmann, and Claude Haan. "Combined Inhibition of Janus and Aurora Kinase Effectively Suppresses Proliferation of JAK2 V617F-expressing Cells." Blood 118, no. 21 (November 18, 2011): 2813. http://dx.doi.org/10.1182/blood.v118.21.2813.2813.
Full textLin, Yipeng. "Kinase inhibitor therapies for Chronic lymphocytic leukaemia (CLL): SYK, BTK and PI3K inhibitors." Highlights in Science, Engineering and Technology 19 (November 17, 2022): 30–35. http://dx.doi.org/10.54097/hset.v19i.2691.
Full textTokuyama, Michio, and Tomotaka Mabuchi. "New Treatment Addressing the Pathogenesis of Psoriasis." International Journal of Molecular Sciences 21, no. 20 (October 11, 2020): 7488. http://dx.doi.org/10.3390/ijms21207488.
Full textAhmadu, Augustine A., Claire Delehouzé, Anas Haruna, Lukman Mustapha, Bilqis A. Lawal, Aniefiok Udobre, Blandine Baratte, et al. "Betulin, a Newly Characterized Compound in Acacia auriculiformis Bark, Is a Multi-Target Protein Kinase Inhibitor." Molecules 26, no. 15 (July 29, 2021): 4599. http://dx.doi.org/10.3390/molecules26154599.
Full textFlis, Sylwia, Ewelina Bratek, Tomasz Chojnacki, Marlena Piskorek, and Tomasz Skorski. "Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia Cells." Cancers 11, no. 10 (October 12, 2019): 1544. http://dx.doi.org/10.3390/cancers11101544.
Full textGrisouard, Jean, Elisa Bouillet, Katharina Timper, Tanja Radimerski, Kaethi Dembinski, Daniel M. Frey, Ralph Peterli, et al. "Both inflammatory and classical lipolytic pathways are involved in lipopolysaccharide-induced lipolysis in human adipocytes." Innate Immunity 18, no. 1 (November 18, 2010): 25–34. http://dx.doi.org/10.1177/1753425910386632.
Full textOkabe, Seiichi, Tetsuzo Tauchi, Seiichiro Katagiri, Yuko Tanaka, and Kazuma Ohyashiki. "Combining ABL1 Kinase Inhibitor, Imatinib and the Jak Kinase Inhibitor TG101348: A Potential Treatment for Residual BCR-ABL Positive Leukemia Cells." Blood 120, no. 21 (November 16, 2012): 3737. http://dx.doi.org/10.1182/blood.v120.21.3737.3737.
Full textBoland, Sonja, Véronique Bonvallot, Thierry Fournier, Armelle Baeza-Squiban, Michel Aubier, and Francelyne Marano. "Mechanisms of GM-CSF increase by diesel exhaust particles in human airway epithelial cells." American Journal of Physiology-Lung Cellular and Molecular Physiology 278, no. 1 (January 1, 2000): L25—L32. http://dx.doi.org/10.1152/ajplung.2000.278.1.l25.
Full textOsses, Nelson, and Enrique Brandan. "ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression." American Journal of Physiology-Cell Physiology 282, no. 2 (February 1, 2002): C383—C394. http://dx.doi.org/10.1152/ajpcell.00322.2001.
Full textBilodeau-Goeseels, Sylvie, Nora Magyara, and Coralie Collignon. "Characterization of the effects of metformin on porcine oocyte meiosis and on AMP-activated protein kinase activation in oocytes and cumulus cells." Zygote 22, no. 2 (April 12, 2013): 275–85. http://dx.doi.org/10.1017/s0967199413000075.
Full textGeorge, Daniel J., Chung-Han Lee, and Daniel Heng. "New approaches to first-line treatment of advanced renal cell carcinoma." Therapeutic Advances in Medical Oncology 13 (January 2021): 175883592110347. http://dx.doi.org/10.1177/17588359211034708.
Full textGiunti, Serena, Alessandro Antonelli, Andrea Amorosi, and Libero Santarpia. "Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma." International Journal of Endocrinology 2013 (2013): 1–16. http://dx.doi.org/10.1155/2013/803171.
Full textNg, Chin Lin, Alaeldin Abdalla, Greta Galambosi, Sinead Cuffe, Brendan Doyle, Brenda Griffin, and Donal J. Sexton. "Acute kidney Injury due to Alectinib, an Anaplastic Lymphoma Kinase inhibitor." Journal of Onco-Nephrology 5, no. 1 (January 27, 2021): 18–22. http://dx.doi.org/10.1177/2399369321989718.
Full textHuynh, Thanh Kieu, Chien-Yi Ho, Chi-Hua Tsai, Chien-Kuo Wang, Yun-Ju Chen, Da-Tian Bau, Chih-Yen Tu, Tzong-Shiun Li, and Wei-Chien Huang. "Proteasome Inhibitors Suppress ErbB Family Expression through HSP90-Mediated Lysosomal Degradation." International Journal of Molecular Sciences 20, no. 19 (September 27, 2019): 4812. http://dx.doi.org/10.3390/ijms20194812.
Full textMayrhofer, Johanna E., Florian Enzler, Andreas Feichtner, Ruth Röck, Jakob Fleischmann, Andrea Raffeiner, Philipp Tschaikner, et al. "Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies." Proceedings of the National Academy of Sciences 117, no. 49 (November 23, 2020): 31105–13. http://dx.doi.org/10.1073/pnas.2012150117.
Full textScarpa, Mario, Shivani Kapoor, Danilo Perrotti, and Maria R. Baer. "Concurrent FLT3 Inhibitor and PP2A Activating Drug Treatment Induces Synergistic Cytotoxicity in Acute Myeloid Leukemia Cells with FLT3 Internal Tandem Duplication through Proteasomal Degradation of Pim-1 and c-Myc." Blood 132, Supplement 1 (November 29, 2018): 3951. http://dx.doi.org/10.1182/blood-2018-99-117609.
Full textMattei, Jean Camille, Corinne Bouvier-Labit, Doriane Barets, Nicolas Macagno, Mathieu Chocry, Frédéric Chibon, Philippe Morando, et al. "Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile." Cancers 12, no. 3 (March 3, 2020): 583. http://dx.doi.org/10.3390/cancers12030583.
Full textNestal de Moraes, Gabriela, Paloma Silva Souza, Fernanda Casal de Faria Costas, Flavia Cunha Vasconcelos, Flaviana Ruade Souza Reis, and Raquel Ciuvalschi Maia. "The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia." Leukemia Research and Treatment 2012 (April 24, 2012): 1–19. http://dx.doi.org/10.1155/2012/671702.
Full textCasado, Pedro, Edmund Wilkes, Marym M. Hadi, Vinothini Rajeeve, Farideh Miraki-Moud, Rebecca Pike, Ana Del Rio-Machin, et al. "Differentiation Status Revealed By Shotgun Phosphoproteomics Determines Sensitivity of Primary AML Cells to Kinase Inhibitors." Blood 128, no. 22 (December 2, 2016): 840. http://dx.doi.org/10.1182/blood.v128.22.840.840.
Full textLaface, Carmelo, Palma Fedele, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Pasquale Molinari, Michele Ammendola, Marco Lioce, and Girolamo Ranieri. "Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities." Cancers 14, no. 16 (August 20, 2022): 4028. http://dx.doi.org/10.3390/cancers14164028.
Full textSaylor, Philip J., and M. Dror Michaelson. "New Treatments for Renal Cell Carcinoma: Targeted Therapies." Journal of the National Comprehensive Cancer Network 7, no. 6 (June 2009): 645–56. http://dx.doi.org/10.6004/jnccn.2009.0045.
Full textReimer, Raylene A. "Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases." Journal of Endocrinology 191, no. 1 (October 2006): 159–70. http://dx.doi.org/10.1677/joe.1.06557.
Full textFinan, P. M., and M. J. Thomas. "PI 3-kinase inhibition: a therapeutic target for respiratory disease." Biochemical Society Transactions 32, no. 2 (April 1, 2004): 378–82. http://dx.doi.org/10.1042/bst0320378.
Full textGray, Mike J., Gloria Wangrong YangKolodji, and Debu Tripathy. "Co-targeting PI3K and ras pathways in trastuzumab resistance." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e13515-e13515. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13515.
Full textGild, Matti L., Iñigo Landa, Mabel Ryder, Ronald A. Ghossein, Jeffrey A. Knauf, and James A. Fagin. "Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells." Endocrine-Related Cancer 20, no. 5 (July 4, 2013): 659–67. http://dx.doi.org/10.1530/erc-13-0085.
Full textWang, Minmin, Tianyu Wang, Xiangyu Zhang, Xiaoxing Wu, and Sheng Jiang. "Cyclin-dependent kinase 7 inhibitors in cancer therapy." Future Medicinal Chemistry 12, no. 9 (May 2020): 813–33. http://dx.doi.org/10.4155/fmc-2019-0334.
Full textWierda, William G., and Francesco Paolo Tambaro. "How I manage CLL with venetoclax-based treatments." Blood 135, no. 17 (April 23, 2020): 1421–27. http://dx.doi.org/10.1182/blood.2019002841.
Full textdos Santos, Tabata M., Renato F. Righetti, Bianca G. Rezende, Elaine C. Campos, Leandro do N. Camargo, Beatriz M. Saraiva-Romanholo, Silvia Fukuzaki, et al. "Effect of anti-IL17 and/or Rho-kinase inhibitor treatments on vascular remodeling induced by chronic allergic pulmonary inflammation." Therapeutic Advances in Respiratory Disease 14 (January 2020): 175346662096266. http://dx.doi.org/10.1177/1753466620962665.
Full textKhan, Zahra, Izabela Stasik, and Joseph Hayes. "Computer-aided Design of Novel CDK5 Inhibitors; Towards New Treatments of Glioblastoma." Neuro-Oncology 24, Supplement_4 (October 1, 2022): iv8. http://dx.doi.org/10.1093/neuonc/noac200.035.
Full textLin, You-Zhe, Yi-Chun Shen, Wan-Rong Wu, Wei-Jan Wang, Yuan-Liang Wang, Chen-Yuan Lin, Mien-Chie Hung, and Shao-Chun Wang. "Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles." International Journal of Molecular Sciences 22, no. 13 (June 28, 2021): 6938. http://dx.doi.org/10.3390/ijms22136938.
Full textKoomoa, Dana-Lynn T., Mark W. Musch, Ainsley Vaz MacLean, and Leon Goldstein. "Volume-activated trimethylamine oxide efflux in red blood cells of spiny dogfish (Squalus acanthias)." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 281, no. 3 (September 1, 2001): R803—R810. http://dx.doi.org/10.1152/ajpregu.2001.281.3.r803.
Full textKiss, Z., and E. Deli. "Regulation of phospholipase D by sphingosine involves both protein kinase C-dependent and -independent mechanisms in NIH 3T3 fibroblasts." Biochemical Journal 288, no. 3 (December 15, 1992): 853–58. http://dx.doi.org/10.1042/bj2880853.
Full textShey, Susan, Sarah Kim, Julie Kim, and Elizabeth J. Murphy. "Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A394—A395. http://dx.doi.org/10.1210/jendso/bvab048.803.
Full textArtamonova, E. V., and E. I. Kovalenko. "Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors." Tumors of female reproductive system 15, no. 2 (September 6, 2019): 30–41. http://dx.doi.org/10.17650/1994-4098-2019-15-2-30-41.
Full textChen, Lisa S., William G. Wierda, Sanjeev Redkar, David J. Bearss, and Varsha Gandhi. "Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes." Blood 112, no. 11 (November 16, 2008): 4199. http://dx.doi.org/10.1182/blood.v112.11.4199.4199.
Full textJacob, Allen, Jaret Shook, and Thomas E. Hutson. "Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma." Future Oncology 16, no. 28 (October 2020): 2147–64. http://dx.doi.org/10.2217/fon-2020-0443.
Full textCiereszko, R., M. Opalka, B. Kaminska, T. Górska, and L. Dusza. "Prolactin signalling in porcine theca cells: the involvement of protein kinases and phosphatases." Reproduction, Fertility and Development 15, no. 1 (2003): 27. http://dx.doi.org/10.1071/rd02049.
Full textMolina-Arcas, Miriam, Christopher Moore, Sareena Rana, Febe van Maldegem, Edurne Mugarza, Pablo Romero-Clavijo, Eleanor Herbert, et al. "Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer." Science Translational Medicine 11, no. 510 (September 18, 2019): eaaw7999. http://dx.doi.org/10.1126/scitranslmed.aaw7999.
Full textWen, Ji, Huifang Hu, Menglin Chen, Hang Yang, Yi Zhao, and Yi Liu. "Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review." Journal of Immunology Research 2021 (December 20, 2021): 1–9. http://dx.doi.org/10.1155/2021/2324400.
Full textDeSilva, Dimuthu R., Elizabeth A. Jones, Margaret F. Favata, Bruce D. Jaffee, Ronald L. Magolda, James M. Trzaskos, and Peggy A. Scherle. "Inhibition of Mitogen-Activated Protein Kinase Kinase Blocks T Cell Proliferation But Does Not Induce or Prevent Anergy." Journal of Immunology 160, no. 9 (May 1, 1998): 4175–81. http://dx.doi.org/10.4049/jimmunol.160.9.4175.
Full textYILDIZ, Çağlar, Zeki ÖZSOY, Turgut KACAN, and Hatice ÖZER. "The Effects of Lapatinib and Trastuzumab in a Rat Model of Endometriosis." Cumhuriyet Science Journal 43, no. 4 (December 27, 2022): 556–63. http://dx.doi.org/10.17776/csj.1168698.
Full textMaster, Samip R., and Richard Preston Mansour. "Cardiovascular Toxicities of Tyrosine Kinase Inhibitor in CML." Blood 136, Supplement 1 (November 5, 2020): 6. http://dx.doi.org/10.1182/blood-2020-143216.
Full textBayley, A., and N. Gullick. "SAT0420 EFFICACY OF NON-TUMOUR NECROSIS FACTOR BIOLOGICS AND TARGETED SYSTEMIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN THE TREATMENT OF PSORIATIC ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1163–64. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4742.
Full textSoleimani, Maryam, Lucia Nappi, and Christian Kollmannsberger. "Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma." Future Oncology 16, no. 36 (December 2020): 3021–34. http://dx.doi.org/10.2217/fon-2020-0586.
Full textOkabe, Seiichi, Tetsuzo Tauchi, Seiichiro Katagiri, Yuko Tanaka, and Kazuma Ohyashiki. "Activity of the Aurora Kinase Inhibitor, MLN8237 (alisertib) Alone or in Combination with Ponatinib Against Imatinib-Resistant BCR-ABL-Positive Cells." Blood 120, no. 21 (November 16, 2012): 1333. http://dx.doi.org/10.1182/blood.v120.21.1333.1333.
Full textHu, Xiangyang, Steven J. Neill, Weiming Cai, and Zhangcheng Tang. "Nitric oxide mediates elicitor-induced saponin synthesis in cell cultures of Panax ginseng." Functional Plant Biology 30, no. 8 (2003): 901. http://dx.doi.org/10.1071/fp03061.
Full textKaramsetty, M. R., J. R. Klinger, and N. S. Hill. "Evidence for the role of p38 MAP kinase in hypoxia-induced pulmonary vasoconstriction." American Journal of Physiology-Lung Cellular and Molecular Physiology 283, no. 4 (October 1, 2002): L859—L866. http://dx.doi.org/10.1152/ajplung.00475.2001.
Full textCovey, Todd M., Michael Gulrajani, Heiko Becker, Jason C. Chandler, Sebastian Schwind, Guido Marcucci, and Alessandra Cesano. "Single Cell Network Profiling as a Platform to Reveal Leukemia-Specific Signaling Signatures and Sensitivity to Kinase Inhibitor Therapies." Blood 116, no. 21 (November 19, 2010): 2753. http://dx.doi.org/10.1182/blood.v116.21.2753.2753.
Full textDai, Jun, LiXi Yang, and Glynn Addison. "Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors." Mini-Reviews in Medicinal Chemistry 19, no. 18 (November 29, 2019): 1531–43. http://dx.doi.org/10.2174/1389557519666190617152011.
Full textConley, B. A., C. M. Leece, S. Chandana, and S. Dowlashati. "Role of mixed lineage kinase 3 in response of head and neck squamous cancer cell lines to epidermal growth factor receptor (EGFR) inhibition." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 6076. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.6076.
Full text